Search by Drug Name or NDC

    NDC 68382-0920-01 Entecavir 0.5 mg/1 Details

    Entecavir 0.5 mg/1

    Entecavir is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is ENTECAVIR.

    Product Information

    NDC 68382-0920
    Product ID 68382-920_b9646f09-8d5b-4271-b2b1-b1d66a91ed73
    Associated GPIs 12352030000320
    GCN Sequence Number 058934
    GCN Sequence Number Description entecavir TABLET 0.5 MG ORAL
    HIC3 W5F
    HIC3 Description HEPATITIS B TREATMENT AGENTS
    GCN 24466
    HICL Sequence Number 032832
    HICL Sequence Number Description ENTECAVIR
    Brand/Generic Generic
    Proprietary Name Entecavir
    Proprietary Name Suffix n/a
    Non-Proprietary Name Entecavir
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 0.5
    Active Ingredient Units mg/1
    Substance Name ENTECAVIR
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206745
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0920-01 (68382092001)

    NDC Package Code 68382-920-01
    Billing NDC 68382092001
    Package 100 TABLET, FILM COATED in 1 BOTTLE (68382-920-01)
    Marketing Start Date 2017-08-10
    NDC Exclude Flag N
    Pricing Information N/A